Why Medtronic (MDT) Should Be Part of Your Dividend Stock Portfolio in 2025

Medtronic plc (NYSE:MDT) is included among the Best Stocks for a Dividend Stock Portfolio.

Medtronic plc (NYSE:MDT), one of the leading names in medical devices, has faced some challenges in recent years but has taken measures to address them, with a particular emphasis on strengthening profitability. In the past, the company considered spinning off certain divisions and ultimately decided to separate its diabetes care segment. This unit, being the only consumer-facing business and carrying thinner margins compared to other operations, is expected to support earnings improvement once separated.

At the same time, Medtronic plc (NYSE:MDT)’s core operations remain solid. As one of the largest medical device makers globally, it serves a wide range of therapeutic areas. Its ongoing efforts to develop and launch innovative products have helped drive steady revenue and profit growth.

In addition, Medtronic plc (NYSE:MDT) is a strong dividend company with 48 consecutive years of dividend growth under its belt. This means that the company is just 2 years away from becoming a Dividend King. The company offers a quarterly dividend of $0.71 per share and has a dividend yield of 2.98%, as of September 18.

While we acknowledge the potential of MDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 13 Best Consistent Dividend Stocks to Buy Now and 15 Best Performing Dividend Stocks So Far in 2025.

Disclosure: None.